U.S. Markets open in 2 hrs

Immunomedics, Inc. (IMMU)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
87.860.00 (0.00%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close87.86
Open87.85
Bid0.00 x 800
Ask0.00 x 2200
Day's Range87.83 - 87.93
52 Week Range8.80 - 87.93
Volume0
Avg. Volume6,658,817
Market Cap20.309B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Gilead's New CEO Is Going All-In on Acquisitions
    Motley Fool

    Gilead's New CEO Is Going All-In on Acquisitions

    Daniel O'Day has made increasingly larger deals in an effort to improve the company's portfolio of cancer drugs.

  • 3 Reasons to Sell Gilead Sciences Now
    Motley Fool

    3 Reasons to Sell Gilead Sciences Now

    Gilead Sciences (NASDAQ: GILD) is a veritable monster in the pharmaceutical industry. Thanks to its industry-leading entry into the coronavirus market this year with its antiviral treatment, remdesivir, Gilead has been a favorite stock for speculative and more critical healthcare investors alike. On the other hand, there are several headwinds that may prevent Gilead's stock from growing as rapidly as its investors might like.

  • Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?
    Motley Fool

    Should You Buy Immunomedics Before the Gilead Sciences Acquisition Closes?

    The company's recent acquisition at a lofty premium looks similar to other Gilead deals. That could mean one of two things for investors.